This element examines the production and application of genetically altered (GA) animals in scientific research, covering techniques from classical transge
Topic Synopsis
This element examines the production and application of genetically altered (GA) animals in scientific research, covering techniques from classical transgenesis to modern gene editing. Learners will explore the scientific justifications for using GA models, their contributions to understanding disease, and the associated welfare and ethical challenges. A critical understanding of the regulatory landscape governing the use of GA animals is essential.
Key Concepts & Core Principles
- The Animals (Scientific Procedures) Act 1986 (ASPA) and its amendments: Understand the legal requirements for licensing, project licenses, personal licenses, and establishment licenses, as well as the role of the Home Office and the Animals in Science Committee.
- The 3Rs (Replacement, Reduction, Refinement): Apply these principles to minimize animal use and suffering, including examples such as using in vitro methods (Replacement), using fewer animals via better experimental design (Reduction), and improving housing and handling (Refinement).
- Species-specific husbandry and welfare: Know the environmental, nutritional, and social needs of common laboratory species (e.g., mice, rats, guinea pigs, rabbits, zebrafish) and how to assess welfare using indicators like body condition, behavior, and clinical signs.
- Health monitoring and disease prevention: Recognize signs of common diseases (e.g., murine norovirus, rabbit pasteurellosis), understand sentinel programs, and implement biosecurity measures such as quarantine and barrier housing.
- Practical techniques: Competence in handling, restraint, dosing (oral, subcutaneous, intraperitoneal), blood sampling (tail vein, saphenous), and euthanasia methods (e.g., cervical dislocation, anesthetic overdose) in accordance with Schedule 1 of ASPA.
Exam Tips & Revision Strategies
- Always relate your answers to the 3Rs (Replacement, Reduction, Refinement) when discussing ethics or regulation.
- Use specific examples of widely used GA models (e.g., the Tg2576 mouse for Alzheimer's disease) to demonstrate application.
- Be precise with terminology: 'genetically altered' encompasses transgenic, gene-edited, and spontaneous mutants.
- When explaining problems, link to genuine scientific literature or regulatory documents (e.g., ASPA 1986) for depth.
Common Misconceptions & Mistakes to Avoid
- Confusing transgenic models (random insertion) with targeted knockout/knock-in models.
- Overlooking the need for genetic monitoring and health screening of GA colonies.
- Assuming that all genetically altered animals will automatically display a disease phenotype or suffer pain.
- Failing to consider the off-target effects of CRISPR/Cas9 and the need for backcrossing.
Examiner Marking Points
- Award credit for accurately describing the steps of pronuclear microinjection or embryonic stem cell targeting.
- Expect explicit identification of welfare issues unique to GA animals, such as unexpected phenotypes or increased susceptibility to disease.
- Credit recognition of the role of the Animal Welfare and Ethical Review Body (AWERB) in project evaluation and harm-benefit analysis.
- Look for correct use of terminology distinguishing transgenic, knockout, knock-in, and conditional models.
- Award marks for explaining the importance of suitable control animals, including wild-type littermates.